SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-206264
Filing Date
2023-08-08
Accepted
2023-08-08 16:31:08
Documents
6
Effectiveness Date
2023-08-08

Document Format Files

Seq Description Document Type Size
1 S-8 d531544ds8.htm S-8 31418
2 EX-5.1 d531544dex51.htm EX-5.1 6486
3 EX-23.1 d531544dex231.htm EX-23.1 1445
4 EX-FILING FEES d531544dexfilingfees.htm EX-FILING FEES 13147
5 GRAPHIC g531544g14r03.jpg GRAPHIC 3587
6 GRAPHIC g531544g28e67.jpg GRAPHIC 3019
  Complete submission text file 0001193125-23-206264.txt   63092
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-273802 | Film No.: 231151925
SIC: 2834 Pharmaceutical Preparations